Is Twist Bioscience Corp (TWST) a risky stock?
As of July 28, 2026, Clavix grades Twist Bioscience Corp (TWST) D- for risk, a composite score of 37 out of 100 on an A+ to F scale, which puts TWST in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 28, 2026. Clavix regrades every trading day.
The five risk dimensions behind TWST's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how TWST scores on each, as of July 28, 2026.
What's moving TWST's risk right now
Company-specific signals Clavix flags behind TWST's current grade, drawn from recent news and filings as of July 28, 2026.
Emerald Mutual Fund Advisers Trust bought a new position in Twist during Q1, and a biotech ETF (XBI) posted a big gain driven mostly by broad sector strength rather than any single stock.
Analysts say Twist's elevated valuation leaves little room for execution missteps, so any stumble in synthetic biology revenue growth could pressure the stock.
Twist announced it will report fiscal 2026 third-quarter financial results on Monday, August 3, 2026.
Recent TWST news
The latest headlines Clavix ingested for Twist Bioscience Corp, newest first. These feed the news-sentiment dimension of TWST's grade.
-
Twist Bioscience (TWST) stock has gained 261.2% over the past three years, but current valuation screens as expensive on multiple metrics, raising concerns about how much growth optimism is already priced into shares.
-
Twist Bioscience (TWST) surged driven by strong results and AI drug discovery demand, highlighted in Artisan Partners' second-quarter 2026 investor letter for its Artisan Small Cap Fund, which modestly outperformed the Russell 2000 Growth Index's 25.7% gain.
What a D- grade means
On the Clavix A+ to F scale, TWST's composite of 37 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell TWST or any security. Grades are risk indicators, not predictions of return. Data may be delayed.